Liu S, Xi Y, Bettaieb A, Matsuo K, Matsuo I, Kulkarni RN, Haj FG. Disruption of protein-tyrosine phosphatase 1B expression in the pancreas affects β-cell function. Endocrinology. 2014;155(9):3329–3338.
Publications
2014
Cannon CE, Titchenell PM, Groff DN, Ouaamari AE, Kulkarni RN, Birnbaum MJ, Stoffers DA. The Polycomb protein, Bmi1, regulates insulin sensitivity. Molecular metabolism. 2014;3(8):794–802.
Xi Y, Liu S, Bettaieb A, Matsuo K, Matsuo I, Hosein E, Chahed S, Wiede F, Zhang S, Zhang Z-Y, et al. Pancreatic T cell protein–tyrosine phosphatase deficiency affects beta cell function in mice. Diabetologia. 2014;58(1):122–131.
Kahraman S, Dirice E, De Jesus DF, Hu J, Kulkarni RN. Maternal insulin resistance and transient hyperglycemia impact the metabolic and endocrine phenotypes of offspring. American Journal of Physiology-Endocrinology and Metabolism. 2014;307(10):E906–E918.
De Jesus DF, Kulkarni RN. Epigenetic modifiers of islet function and mass. Trends in Endocrinology & Metabolism. 2014;25(12):628–636.
Kulkarni RN, Stewart AF. Summary of the Keystone islet workshop (April 2014): the increasing demand for human islet availability in diabetes research. 2014.
2013
Liew CW, Boucher J, Cheong JK, Vernochet C, Koh H-J, Mallol C, Townsend K, Langin D, Kawamori D, Hu J, et al. Ablation of TRIP-Br2, a novel regulator of fat lipolysis, thermogenesis and oxidative metabolism, prevents diet-induced obesity and insulin resistance. Nature medicine. 2013.
Teo AK, Windmueller R, Johansson BB, Dirice E, Njolstad PR, Tjora E, Raeder H, Kulkarni RN. Derivation of human induced pluripotent stem cells from patients with maturity onset diabetes of the young. Journal of Biological Chemistry. 2013;288(8):5353–5356.
Aukrust I, Bj\orkhaug L, Negahdar M, Molnes J, Johansson BB, Müller Y, Haas W, Gygi SP, S\ovik O, Flatmark T, et al. SUMOylation of pancreatic glucokinase regulates its cellular stability and activity. Journal of Biological Chemistry. 2013;288(8):5951–5962.
Ouaamari AE, Kawamori D, Dirice E, Liew CW, Shadrach JL, Hu J, Katsuta H, Hollister-Lock J, Qian W-J, Wagers AJ, et al. Liver-derived systemic factors drive β cell hyperplasia in insulin-resistant states. Cell reports. 2013;3(2):401–410.